Current Trends in Use and Outcomes of Left Atrial Appendage Closure (Sachin Goel, MD)
Objectives:
1. Review randomized and registry data on LAAC with Watchman Device, with a focus on improving safety with newer iterations.
2. Review the importance of complications of LAAC, specifically peridevice leak (PDL) and device-related thrombus (DRT).
3. Review data on the Amulet device and newer LAAC devices.
** This medical education program may contain graphic content. **
_________________________________
A DeBakey CV Education event
Presented by Houston Methodist DeBakey Heart & Vascular Center.
Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases.
FOR MORE INFORMATION
DeBakey CV Education:
www.houstonmethodist.org/educ...
For the latest education and training opportunities from DeBakey CV Education: bit.ly/HMdebakeyemail
Follow Us:
Twitter: / debakeycvedu
Livestream: livestream.com/debakey
SmugMug: debakey.smugmug.com/
Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door.
journal.houstonmethodist.org/
Пікірлер: 1
So PROTECT showed no significant difference in ischemic stroke but a significant reduction in CV death….how does this make any sense clinically? How else would a LAAO device reduce CV mortality? Honest question. Also CT showing leaks in more than half of cases isnt a good look either for Watchman.